Ladder Capital Equity Method Investments decreased by 0.6% to $44.21M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 130.4%, from $19.19M to $44.21M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows relatively stable performance with a -0.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.82M | $26.08M | $23.15M | $5.24M | $5.60M | $6.01M | $6.22M | $6.34M | $6.55M | $7.03M | $6.88M | $6.86M | $20.01M | $19.99M | $19.92M | $19.19M | $18.90M | $18.49M | $44.47M | $44.21M |
| QoQ Change | — | -31.0% | -11.2% | -77.4% | +6.8% | +7.3% | +3.5% | +1.9% | +3.4% | +7.3% | -2.2% | -0.2% | +191.5% | -0.1% | -0.3% | -3.7% | -1.5% | -2.2% | +140.5% | -0.6% |
| YoY Change | — | — | — | — | -85.2% | -77.0% | -73.1% | +20.8% | +17.0% | +17.1% | +10.6% | +8.3% | +205.3% | +184.3% | +189.7% | +179.7% | -5.5% | -7.5% | +123.2% | +130.4% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Real Estate | $19.20M | $18.90M | $18.50M | $44.50M | $44.20M |
| Total | $19.19M | $18.90M | $18.49M | $44.47M | $44.21M |